ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: HTML, PDF (Size: 131K)  | Related Articles | Citation Tracking

Annotation
The fragile X continuum: new advances and perspectives
K. Cornish, 1 J. Turk 2 & R. Hagerman 3
  1 McGill Child Laboratory for Research and Education in Developmental Disorders, McGill University, Montréal, Canada
  2 Division of Clinical Developmental Sciences, St. George's, University of London, Cranmer Terrace, London, UK
  3 Department of Pediatrics and M.I.N.D. Institute, University of California at Davis, School of Medicine, Sacramento, CA, USA
Correspondence to  Professor Kim Cornish, McGill University, 3700 McTavish Street, Montreal, H3A 1Y2, Canada (e-mail: kim.cornish@mcgill.ca).
Copyright Journal compilation © 2008 Blackwell Publishing Ltd
KEYWORDS
autism • fragile X syndrome • FXTAS • FMRP • intellectual disability • premutation

ABSTRACT

Fragile X syndrome is the world's most common hereditary cause of intellectual disability in men and to a lesser extent in women. The disorder is caused by the silencing of a single gene on the X chromosome, the Fragile X Mental Retardation Gene-1. A substantial body of research across the disciplines of molecular genetics, child psychiatry and developmental neuroscience bears testament to a decade of exciting and innovative science that has advanced our knowledge about the fragile X 'signature' or influence across cognitive and social development. The core aims of this review are to first discuss fragile X syndrome and premutation involvement in the context of current advances that demonstrate the dynamic nature of the genotype on phenotypic outcomes. Second, to discuss the implications of these recent advances for the development of clinical and educational interventions and resource tools that target specific phenotypic 'signatures' within the fragile X continuum.


Accepted 17 March 2008

DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1365-2788.2008.01056.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member